Oxlumo (lumasiran) - Alnylam
Leqvio (inclisiran) - Novartis
Qfitlia (fitusiran) - Sanofi
Givlaari (givosiran) - Alnylam
SAL0132 - Shenzhen Salubris
Amvuttra (vutrisiran) - Alnylam
Redemplo (plozasiran) - Arrowhead Pharmaceuticals
Rivfloza (nedosiran) - Novo Nordisk
http://www.ncbi.nlm.nih.gov/pubmed/42112102
 
Kangna Cao; Ruijie Zhang; Xiaoqing Fan; Xiaoyu Yan; Ying Xiao
 
May 12, 2026
 
Prev Next